The research of hepatoprotective activity in experimental hepatitis influenced by 1,2,4-triazole derivatives

Authors

  • I. M. Bilay
  • E. O. Mihayluk
  • V. V. Parchenko
  • A. G. Kaplaushenko
  • A. I. Panasenko
  • E. G. Knysh

DOI:

https://doi.org/10.14739/2409-2932.2014.2.26165

Keywords:

Pharmacological Actions, Drug Screening, Animal Experimental, Toxic Hepatitis, 1, 2, 4-triazole

Abstract

Aim. The search of new high-effective drugs is an actual problem of modern science. The purpose of our research was the pharmacological screening of 1,2,4-triazoles derivatives. Experiments have been performed on adult Wistar white rats.

Methods and results. Compounds have been entered in a 1/10 dose of LD50, which have been determined before performing experiments. The article presents hepatoprotective activity of new synthesized compounds in simulated acute liver injury. We present a comparison with reference drugs in the experiment.

Сonclusion. Screening has shown that these class of compounds is promising for further research.

References

Stefanov, O. V. (Ed.) (2001) Doklinichni doslidzhenia likarskikh zakhodiv [Preclinic investigation medicines]. Kyiv: Avicena. [in Ukrainian].

Morozov, S. Yu. (2009) Gepatoprotektory v praktike vracha-klinicista [Hepatoprotectors in practic work of clinic doctor]. Russkij medicinskij zhurnal, 11(1), 25. [in Russian].

Polunina, T. E., Maev, I. V., & Polunina, E. V. (2009) Hepatologiya dlya practicheskogo vracha [Hepatology for practic doctor]. Moscow: Avtorskaya academiya. [in Russian].

Prozorovskii, V. B. (2007) Statisticheskaya obrabotka rezul'tatov farmakologicheskikh issledovanij [Statistic processing of data of pharmacological investigations]. Psikhofarmakologiya i biologicheskaya narkologiya, 7(3-4), 2090–2120. [in Russian].

Tkach, S. M. (2009) [Effectiveness and safety hepatoprotectors terms of evidence-based medicine]. Zdorov`e Ukrainy, 6, 7–10. [inUkrainian].

Donnelly, K. L., Smith, C. I., Schwarzenberg, S. J., et al. (2005) Sources of fatty acids stored in liver and secreted via lipoproteins in patients with non–alcoholic fatty liver disease. J Clin Invest, 115(5), 1343–1351.

Downloads

How to Cite

1.
Bilay IM, Mihayluk EO, Parchenko VV, Kaplaushenko AG, Panasenko AI, Knysh EG. The research of hepatoprotective activity in experimental hepatitis influenced by 1,2,4-triazole derivatives. Current issues in pharmacy and medicine: science and practice [Internet]. 2014Jul.8 [cited 2024Dec.24];(2). Available from: http://pharmed.zsmu.edu.ua/article/view/26165

Issue

No. 2 (2014)

Section

Experimental and clinical pharmacology

License

Authors who publish with this journal agree to the following terms:

    1. Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.     Лицензия Creative Commons
    2. Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
    3. Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access)